August 3, 2015 — Biotronik announced CE approval of 3 Tesla (T)...
Implantable Cardioverter Defibrillator (ICD)
This channel includes news and new technology innovations for implantable cardioverter defibrillator, ICD, used to treat tachycardia arrhythmias and heart failure. This includes CRT-Ds.
Feature | Cardiac Resynchronization Therapy Devices (CRT) | July 28, 2015
July 28, 2015 — Biotronik announced the first patients have been successfully implanted with Itrevia HF-T QP cardiac...
Feature | Implantable Cardioverter Defibrillator (ICD) | July 02, 2015
July 2, 2015 - Boston Scientific has initiated a worldwide study to evaluate the rate and causes of shocks for...
Feature | Implantable Cardioverter Defibrillator (ICD) | June 23, 2015
June 23, 2015 - Heart attack patients age 65 and older who have reduced heart function might still benefit from...
News | June 02, 2015
June 2, 2015 — The Valley Hospital has been selected as the United States Coordinating Center for the international...
Blog | May 22, 2015
There were several technology takeaway messages for the future of electrophysiology (EP) at the Heart Rhythm Society...
News | May 21, 2015
May 21, 2015 — Clinical trial results showed that full-body magnetic resonance imaging (MRI) scans do not affect the...
Feature | EP Lab | May 15, 2015
May 15, 2015 — A new expert consensus statement by the Heart Rhythm Society (HRS) recommends...
Technology | May 15, 2015
May 15, 2015 — Geneva Healthcare will showcase a set of new features on The Geneva Healthcare Suite – a technology...
St. Jude Medical's Ellipse ICD
News | May 15, 2015
May 15, 2015 — St. Jude Medical Inc. announced CE Mark approval of expanded labeling for its Ellipse...
News | May 15, 2015
May 15, 2015 — Accreditation for Cardiovascular Excellence (ACE) has just released the first-ever...
News | May 11, 2015
May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP)...
News | May 11, 2015
May 11, 2015 — Boston Scientific Corp. presented an overview of its continued business momentum and long-term growth...
